Pneumococcal Pneumonia: Capsular Polysaccharide Antigenemia and Antibody Responses
- 29 February 1976
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 84 (3) , 254-260
- https://doi.org/10.7326/0003-4819-84-3-254
Abstract
Capsular polysaccharide was detected in the serum in 19 of 46 patients with pneumococcal pneumonia. Antigenemia was strongly associated with bacteremia and with infection by low-numbered serotypes. During antibiotic therapy, the concentration of polysaccharide in the circulation declined progressively, but circulating antigen remained detectable in 2/3 of cases for 2 wk or longer. The development of measurable type-specific antibody was delayed in patients with antigenemia. It is not known whether this delay was due to diminished antibody production or to neutralization of antibody by circulating antigen. Despite effective antibiotic therapy many patients with antigenemia had a severe and protracted illness; this may have been related to diminished availability of antibody early in the infection.Keywords
This publication has 5 references indexed in Scilit:
- Pneumococcal Pneumonia Treated with AntibioticsNew England Journal of Medicine, 1954
- THE INHIBITION OF SURFACE PHAGOCYTOSIS BY THE CAPSULAR "SLIME LAYER" OF PNEUMOCOCCUS TYPE IIIThe Journal of Experimental Medicine, 1949
- THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC LUNGSThe Journal of Experimental Medicine, 1942
- THE PATHOGENESIS AND PATHOLOGY OF EXPERIMENTAL TYPE I PNEUMOCOCCIC PNEUMONIA IN THE MONKEYThe Journal of Experimental Medicine, 1942
- IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINEJournal of Clinical Investigation, 1940